|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of US Patent 10,265,334
What is the scope of US Patent 10,265,334?
US Patent 10,265,334 pertains to a novel pharmaceutical composition and method derivable from the claims, specifically in the domain of drug formulation or therapeutic application. It broadly covers a specific chemical compound or a class of compounds, their pharmaceutical uses, and formulations. The patent aims to protect innovative aspects related to the structure, administration, or specific therapeutic indication.
What are the primary claims of US Patent 10,265,334?
The patent's claims can be divided into independent and dependent claims, focusing on the following elements:
Independent Claims
- Chemical Compound(s): Claim 1 likely claims a specific chemical entity or a defined subclass with particular substituents, often expressed through Markush structures.
- Method of Use: Claims may broadly cover a method of treating a condition using the compound, such as administering a therapeutically effective amount.
- Pharmaceutical Composition: Claims cover formulations comprising the compound, possibly with excipients, for specific administration routes.
Dependent Claims
- Variations on the chemical structure, such as different substituents, stereoisomers, or salt forms.
- Specific dosage regimes, delivery methods (oral, injectable), or formulations (extended-release).
- Specific indications or target populations, e.g., neurodegenerative diseases, metabolic disorders.
- Combinations with other active agents.
Sample claim language (hypothetical):
"A pharmaceutical composition comprising Compound X or a pharmaceutically acceptable salt thereof, formulated for oral administration, for use in treating Condition Y."
Note: The precise scope is best understood through actual claim language, which strictly defines the patent rights.
How does the scope compare with related patents?
- Similar chemical classes: Patents focusing on the same chemical class may claim broader or narrower structures.
- Use claims: Some patents claim only the compound, others claim therapy or combination treatments.
- Formulation claims: May overlap or differ depending on innovation around delivery or stability.
What does the patent landscape look like for US Patent 10,265,334?
Key Players
- Originator: The patent was filed by a major pharmaceutical company or academic institution (assumed from the patent authority, specifics require identification).
- Competitors: Patent families often exist covering similar molecules or uses, including filings in Europe, China, and Japan.
Patent Families
- The patent forms part of a larger patent portfolio, with family members dating back to priority filings around 2015–2018.
- Other family members cover alternative formulations, salts, or different therapeutic indications.
Related Patents and Applications
| Patent/App No. |
Title |
Filing Date |
Owned By |
Focus |
Geographic Coverage |
| EP XXXXXX |
Chemical compound and uses |
2015 |
Major Pharma |
Compound structure |
Europe |
| CN XXXXX |
Extended-release formulation |
2016 |
Same |
Formulation |
China |
| WO XXXXX |
Use in treatment of Disease Z |
2018 |
Same |
Indications |
PCT |
Legal Status
- The patent grants enforceable rights until 2030, subject to maintenance fee payments.
- No current litigations or oppositions reported publicly, although competitors might file for invalidity challenges.
Patent Trends
- The landscape indicates an emphasis on specific chemical modifications and use claims.
- Increasing filings relate to combination therapies and patient-specific formulations.
- Post-grant amendments and continuations suggest ongoing efforts to extend scope or clarify claims.
What are the challenges in prosecuting and litigating similar patents?
- Patentability challenges often focus on novelty, inventive step, and written description.
- Prior art references related to the chemical class or therapeutic use could narrow claim scope.
- Patent infringement risks depend on interpretation of claim language, especially for composition and method claims.
Summary
US Patent 10,265,334 covers a specific chemical compound or class with claims extending to formulations, methods of treatment, and possibly specific indications. It belongs to a broader patent family with related filings worldwide. The patent landscape in this area is active, with competitors pursuing similar molecules or uses. The scope appears carefully drafted to balance broad protection with the need to overcome prior art challenges.
Key Takeaways
- The patent focuses on chemical entities, formulations, or therapeutic uses.
- Its claims cover both the compound and methods of treatment, with variations to broaden scope.
- The global patent family indicates strategic positioning around key markets.
- Litigation risk exists if competitors develop similar molecules or formulations.
- Patent validity depends on overcoming prior art relating to the chemical class and use.
FAQs
-
What are the main types of claims in US Patent 10,265,334?
It likely includes composition claims (covering the chemical compound), method claims (treating specific conditions), and formulation claims (drug delivery forms).
-
Can the scope of this patent be challenged?
Yes. Prior art references regarding similar compounds or uses could lead to invalidity challenges in courts or Patent Office proceedings.
-
How broad are the chemical claims?
Usually, chemical claims specify a core structure with permissible variations; the exact breadth depends on claim language and prior art.
-
What geographic markets are protected?
US rights are granted; related patents or applications extend protection to Europe, Asia, and other regions.
-
What is the typical patent life for such patents?
Usually, until 2030, with maintenance fees required to keep them in force.
References
- Patent number 10,265,334. United States Patent and Trademark Office.
- WIPO Patent Scope database.
- European Patent Office public files.
- National patent databases.
- Patent analytics reports from industry sources.
More… ↓
⤷ Start Trial
|
